Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 171,072 shares at $9.36 ($1.6M) on 2018-06-22, disclosed to the SEC on 2018-06-22.
Open-market sale of $1.6M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.33 | 26,492 | $247K | 15.6% |
| 2 | $9.33 | 26,492 | $247K | 15.6% |
| 3 | $9.06 | 18,987 | $172K | 10.8% |
| 4 | $9.06 | 18,987 | $172K | 10.8% |
| 5 | $9.36 | 40,057 | $375K | 23.6% |
| 6 | $9.36 | 40,057 |
| $375K |
| 23.6% |
| Total | $9.28 avg | 171,072 | $1.6M | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |